Pharma giants pour £millions into NHS to push drug sales

Drug firms have long funded groups that lobby for greater investment in their disease areas, paying generous consultancy fees to influential ­healthcare professionals, including up to £480,000 each to GPs who worked as clinical leads for NHS England. In 2022, payments to UK health professionals and organisations reached £200million.